G09 Stock Overview
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Genomic Vision Société Anonyme Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.0017 |
| 52 Week High | €0.058 |
| 52 Week Low | €0.0002 |
| Beta | -0.64 |
| 11 Month Change | 0% |
| 3 Month Change | 13.33% |
| 1 Year Change | -79.52% |
| 33 Year Change | -99.79% |
| 5 Year Change | -99.26% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| G09 | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.2% | -1.9% |
| 1Y | -79.5% | -9.8% | 12.3% |
Return vs Industry: G09 underperformed the German Biotechs industry which returned -24.5% over the past year.
Return vs Market: G09 underperformed the German Market which returned 0.3% over the past year.
Price Volatility
| G09 volatility | |
|---|---|
| G09 Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 6.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: G09's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine G09's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 33 | Aaron Bensimon | www.genomicvision.com |
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company provides FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision S, an automated scanner that develops life science research applications of single DNA molecules analysis and delivers fluorescence imaging; FiberSmart, an analysis software for replication combing assays; and accessories, which include combicoverslips, disposable DNA reservoirs, coverslips stickers, and bench holders. It offers FiberProbes; HexaCard, a genomic vision molecular combing technology offering a streamline one-stop-shop solution for biomanufacturing industries; TeloSizer, a novel tool for measurements of physical telomere length that can be applied to various model organisms; and EasyComb, EasyScan, and EasyComb Plus services.
Genomic Vision Société Anonyme Fundamentals Summary
| G09 fundamental statistics | |
|---|---|
| Market cap | €692.90k |
| Earnings (TTM) | -€10.62m |
| Revenue (TTM) | €1.56m |
0.4x
P/S Ratio-0.1x
P/E RatioIs G09 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| G09 income statement (TTM) | |
|---|---|
| Revenue | €1.56m |
| Cost of Revenue | €134.00k |
| Gross Profit | €1.43m |
| Other Expenses | €12.05m |
| Earnings | -€10.62m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Feb 29, 2024
| Earnings per share (EPS) | -0.028 |
| Gross Margin | 91.43% |
| Net Profit Margin | -679.16% |
| Debt/Equity Ratio | -16.5% |
How did G09 perform over the long term?
See historical performance and comparison